Glycolate 2 Tablet contains Glycopyrrolate 2mg, an anticholinergic agent used primarily to reduce excessive salivation and respiratory secretions. It functions by competitively inhibiting the action of acetylcholine on muscarinic receptors, thereby decreasing secretions in the respiratory tract, gastrointestinal tract, and other exocrine glands. Glycopyrrolate is commonly prescribed in clinical settings for patients undergoing surgery to reduce salivary and respiratory secretions, as well as for the management of conditions such as peptic ulcers, chronic obstructive pulmonary disease (COPD), and hyperhidrosis. The drug’s quaternary ammonium structure limits its ability to cross the blood-brain barrier, resulting in fewer central nervous system side effects compared to other anticholinergics. Glycolate 2 Tablet should be administered as directed by a healthcare professional, with dosage adjustments based on the patient’s condition and response to therapy. Common adverse effects may include dry mouth, blurred vision, urinary retention, and constipation. Caution is advised in patients with glaucoma, urinary tract obstruction, or cardiovascular disease. Glycopyrrolate is contraindicated in individuals with hypersensitivity to the drug or other anticholinergic agents. Regular monitoring and adherence to prescribed dosage are essential to ensure therapeutic efficacy and minimize potential side effects.